Impact of lung metastasis on overall survival (OS) in the phase III SELECT study with lenvatinib (LEN) in patients (pts) with radioiodine refractory differentiated thyroid cancer (RR-DTC)-MedSci.cn

Impact of lung metastasis on overall survival (OS) in the phase III SELECT study with lenvatinib (LEN) in patients (pts) with radioiodine refractory differentiated thyroid cancer (RR-DTC)

Tahara, M; Kiyota, N; Hoff, AO; Badiu, C; Owonikoko, TK; Dutcus, CE; Suzuki, T; Ren, M; Misir, S; Wirth, LJ

ANNALS OF ONCOLOGY, 2019; 30 (): 756

科室
- - 订阅+
  - 更多科室
工具
服务